# Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

> **NCT07037836** · PHASE2 · RECRUITING · sponsor: **Bastiaan Driehuys** · enrollment: 10 (estimated)

## Conditions studied

- COPD (Chronic Obstructive Pulmonary Disease)
- Hypoxemia

## Interventions

- **DRUG:** Inhaled Treprostinil (Tyvaso Nebulizer)

## Key facts

- **NCT ID:** NCT07037836
- **Lead sponsor:** Bastiaan Driehuys
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-29
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07037836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07037836, "Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07037836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*